Corporate

/h/y/s/novartis_317.jpg

Hogan Lovells wins the top role for Novartis in $9bn pharma deal

Hogan Lovells and Cravath Swaine & Moore have won the top roles on Novartis’ $9bn purchase of Chicago-based gene therapy company AveXis. The deal, in which the Swiss pharmaceutical giant is offering $218 per share for AveXis, is being led by Hogan Lovells Washington DC-based corporate transactions partner Joseph Gilligan who is advising Novartis. He is working alongside New […]

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3723 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here